Abbvie INC (ABBV) Shares Declined While Profund Advisors LLC Decreased Its Stake

May 3, 2018 - By Mark Williams

AbbVie Inc. (NYSE:ABBV) Corporate LogoBig Money Sentiment decreased to 0.8 in 2017 Q4. It has change of 0.05, from 2017Q3’s 0.85. The ratio dropped due to ABBV positioning: 42 sold and 695 reduced. 139 funds bought stakes and 448 increased stakes. Investors holded 1.06 billion in 2017Q3 but now own 1.06 billion shares or 0.35% more. Novare Capital Mngmt Lc stated it has 0.89% of its capital in AbbVie Inc. (NYSE:ABBV). Autus Asset Mngmt Limited Company reported 15,075 shs or 0.27% of all its holdings. Beacon Fincl Group Incorporated holds 0.16% of its capital in AbbVie Inc. (NYSE:ABBV) for 9,495 shs. Trustmark Savings Bank Trust Department has invested 0.47% in AbbVie Inc. (NYSE:ABBV). Baker Avenue Asset Mgmt LP accumulated 27,176 shs or 0.25% of the stock. Liberty Mutual Group Asset Inc stated it has 0.18% of its capital in AbbVie Inc. (NYSE:ABBV). Moreover, Mariner Wealth Advsr has 0.12% invested in AbbVie Inc. (NYSE:ABBV) for 31,037 shs. Moreover, Mirae Asset Investments Communications Limited has 0.14% invested in AbbVie Inc. (NYSE:ABBV). United Kingdom-based Lombard Odier Asset Mgmt (Europe) Limited has invested 0.11% in AbbVie Inc. (NYSE:ABBV). Horseman Cap invested in 0.43% or 21,000 shs. Cibc Asset Mgmt holds 0.11% of its capital in AbbVie Inc. (NYSE:ABBV) for 181,246 shs. Jensen Inv Mngmt stated it has 28,500 shs. New England Rech & Mngmt has 4,533 shs. Grimes And stated it has 0.3% in AbbVie Inc. (NYSE:ABBV). Northstar Invest Ltd Liability Company has 0.21% invested in AbbVie Inc. (NYSE:ABBV) for 11,843 shs.

ABBV had 11 selling transactions and 0 insider buys since December 14, 2017. This’s net activity of $47.70 million. Michael Robert A. sold $512,853 worth of AbbVie Inc. (NYSE:ABBV) or 4,294 shs on Wednesday, February 28. Shares for $8.31M were sold by CHASE WILLIAM J on Wednesday, February 28. On Wednesday, February 28 $157,458 worth of stock was sold by SALEKI-GERHARDT AZITA. ALBAN CARLOS sold $9.57M worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28. The insider Schumacher Laura J sold 145,510 shs worth $14.07 million. $976,084 worth of AbbVie Inc. (NYSE:ABBV) shs were sold by GONZALEZ RICHARD A.

According to 2017Q4 SEC form the Profund Advisors Llc decreased its holdings in Abbvie Inc (ABBV) by 10.79%. 73,623 shares were sold by Profund Advisors Llc as the company’s stock declined 6.31% with the market. At the end of 2017Q4, the 608,615 shares of the major pharmaceuticals company held by the institutional investor were valued at $58.86 million, down from 682,238 at the end of the previous reported quarter. Abbvie Inc has $158.89 billion market cap. Ticker’s shares touched $100.14 during the last trading session after 0.23% change.AbbVie Inc. has volume of 2.72 million shares. Since May 3, 2017 ABBV has risen 39.20% and is uptrending. ABBV outperformed the S&P500 by 27.65%.

Profund Advisors Llc operates about $4.85B and $2.59 billion US Long portfolio. Its stake in Amazon Com Inc (NASDAQ:AMZN) was rose by 3,314 shares to 51,024 shares valued at $59.67M in 2017Q4, according to the filing. Profund Advisors Llc has risen its stake in Texas Instrs Inc (NASDAQ:TXN) and also increased its holding in Bank Amer Corp (NYSE:BAC) by 260,572 shares in the quarter, for a total of 619,539 shares.

AbbVie Inc. (NYSE:ABBV) Ratings Coverage

In total 13 analysts cover AbbVie (NYSE:ABBV). “Buy” rating has 6, “Sell” are 1, while 6 are “Hold”. (NYSE:ABBV) has 46% bullish analysts. With $15700 highest and $80 lowest target price, AbbVie has $119.18 average target price or 19.01% above the current ($100.14) price. 25 are the (NYSE:ABBV)’s ratings reports on May 3, 2018 according to StockzIntelligence Inc. In Friday, January 26 report Cowen & Co maintained it with “Buy” rating and $130.0 target. On Friday, March 23 the company was maintained by BMO Capital Markets. On Friday, April 27 the company was maintained by Credit Suisse. In Tuesday, January 16 report Jefferies maintained the stock with “Buy” rating. On Thursday, March 22 Bernstein maintained the shares of ABBV in report with “Hold” rating. On Monday, April 30 Morgan Stanley maintained AbbVie Inc. (NYSE:ABBV) rating. Morgan Stanley has “Equal-Weight” rating and $110 target. On Friday, January 26 Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating. Jefferies has “Buy” rating and $150.0 target. On Thursday, January 4 the stock has “Buy” rating by Jefferies. On Monday, January 29 the rating was downgraded by Leerink Swann to “Hold”. On Thursday, April 5 the firm has “Equal-Weight” rating by Barclays Capital given.

AbbVie Inc. (NYSE:ABBV) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: